Mélanie Tichet

1.7k citations

20 papers · 1.1k indexed · h-index 16

Co-authors: Sophie Tartare‐Deckert Stéphane Rocchi Marcel Deckert Robert Ballotti Douglas Hanahan Nina Fenouille Mickaël Ohanna Aude Mallavialle
Topics: Cancer Immunotherapy and Biomarkers (5 papers)Bone and Dental Protein Studies (4 papers)Immunotherapy and Immune Responses (4 papers)
Cited by: Oncology Immunology Cancer Research
Journals: Science Nature Communications Blood
Partner nations: France Switzerland United States

In The Last Decade

Mélanie Tichet

19 papers receiving 1.1k citations

Peers

Countries citing papers authored by Mélanie Tichet

Since Specialization

Citations

This map shows the geographic impact of Mélanie Tichet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Tichet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Tichet more than expected).

Fields of papers citing papers by Mélanie Tichet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Tichet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Tichet. The network helps show where Mélanie Tichet may publish in the future.

Co-authorship network of co-authors of Mélanie Tichet

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Tichet. A scholar is included among the top collaborators of Mélanie Tichet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Tichet. Mélanie Tichet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A new effLuc/Kate dual reporter allele for tumor imaging in mice 2025 ·Disease Models & Mechanisms ·Latifa Bakiri,Mélanie Tichet,Carolina Marques,Martin K. Thomsen,(unknown),(unknown),(unknown),Kazuhiko Matsuoka,Massimo Squatrito,Douglas Hanahan,Erwin F. Wagner	0
2	Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages 2023 ·Immunity ·Mélanie Tichet,Stephan Wullschleger,Agnieszka Chryplewicz,Nadine Fournier,Rachel Marcone,Annamaria Kauzlaric,Krisztián Homicskó,Laura Codarri Deak,Pablo Umaña,Christian Klein,Douglas Hanahan	80
3	Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity 2022 ·Cancer Cell ·Agnieszka Chryplewicz,(unknown),Mélanie Tichet,Anoek Zomer,Ksenya Shchors,Johanna A. Joyce,Krisztián Homicskó,Douglas Hanahan	82
4	Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion 2022 ·Science ·Qiqun Zeng,Sadegh Saghafinia,Agnieszka Chryplewicz,Nadine Fournier,(unknown),Yuqing Xie,(unknown),(unknown),(unknown),José A. Galván,Eva Karamitopoulou,Inti Zlobec,(unknown),(unknown),Peng Zhang,(unknown),Mark A. Rubin,Mélanie Tichet,Krisztián Homicskó,Douglas Hanahan	62
5	Abstract 71: The immunocytokine PD1-IL2v overcomes immune checkpoint resistance, and combination with an anti-PD-L1 antibody further enhances its anti-tumor activity 2021 ·Cancer Research ·Stephan Wullschleger,Mélanie Tichet,Laura Codarri Deak,Pablo Umaña,Christian Klein,Douglas Hanahan	1
6	Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers 2019 ·Cancer Immunology Research ·(unknown),Stephan Wullschleger,Mélanie Tichet,Dhaarini Murugan,Nadine Zangger,Wesley Horton,Alan J. Korman,Lisa M. Coussens,Melody A. Swartz,Douglas Hanahan	28
7	Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway 2019 ·Oncogene ·Moeez Rathore,Christophe A. Girard,Mickaël Ohanna,Mélanie Tichet,(unknown),Esther García,Frédéric Larbret,Maéva Gesson,Stéphane Audebert,J.‐P. Lacour,Henri Montaudié,Virginie Prod’homme,Sophie Tartare‐Deckert,Marcel Deckert	64
8	ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis 2019 ·Developmental Cell ·Iacovos P. Michael,Sadegh Saghafinia,Mélanie Tichet,Nadine Zangger,Ilaria Marinoni,Aurel Perren,Douglas Hanahan	30
9	Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies 2018 ·Molecular Cancer Therapeutics ·(unknown),Aude Mallavialle,(unknown),(unknown),Mélanie Tichet,Patrick Auberger,Frédéric Luciano,Mickaël Ohanna,Sophie Tartare‐Deckert,Marcel Deckert	44
10	Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice 2018 ·Cancer Immunology Research ·(unknown),Mélanie Tichet,Sonia Domingos‐Pereira,Sylvie Hauert,Denise Nardelli‐Haefliger,Melody A. Swartz,Douglas Hanahan,Stephan Wullschleger	30
11	Cellular endogenous NAD(P)H fluorescence as a label‐free method for the identification of erythrocytes and reticulocytes 2018 ·Cytometry Part A ·(unknown),Vasco Campos,Mélanie Tichet	2
12	SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness 2015 ·Cancer Research ·David Crottès,Raphaël Rapetti‐Mauss,Francisca Alcaraz‐Pérez,Mélanie Tichet,(unknown),Sonia Martial,Hélène Guizouarn,Bernard Pellissier,Agnès Loubat,Alexandra Popa,Agnès Paquet,Marco Presta,Sophie Tartare‐Deckert,María L. Cayuela,Patrick Martin,Franck Borgèse,Olivier Soriani	53
13	Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis 2015 ·Nature Communications ·Mélanie Tichet,Virginie Prod’homme,Nina Fenouille,Damien Ambrosetti,Aude Mallavialle,Michaël Cerezo,Mickaël Ohanna,Stéphane Audebert,Stéphane Rocchi,Damien Giacchero,F. Boukari,Maryline Allégra,Jean‐Claude Chambard,J.‐P. Lacour,Jean‐François Michiels,Jean‐Paul Borg,Marcel Deckert,Sophie Tartare‐Deckert	157
14	Risk for Nevus Transformation and Melanoma Proliferation and Invasion During Natalizumab Treatment 2014 ·JAMA Dermatology ·(unknown),Mélanie Tichet,Christine Lebrun‐Frénay,Sophie Tartare‐Deckert,Thierry Passeron	11
15	Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner 2013 ·Molecular Cancer Therapeutics ·Michaël Cerezo,Mélanie Tichet,Patricia Abbe,Mickaël Ohanna,Abdelali Lehraiki,Florian Rouaud,(unknown),Damien Giacchero,Philippe Bahadoran,Corine Bertolotto,Sophie Tartare‐Deckert,Robert Ballotti,Stéphane Rocchi	174
16	The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion 2012 ·PLoS ONE ·Nina Fenouille,Mélanie Tichet,Maeva Dufies,(unknown),Ariane Mogha,(unknown),Stéphane Rocchi,Aude Mallavialle,Marie‐Dominique Galibert,Amir Khammari,J.‐P. Lacour,Robert Ballotti,Marcel Deckert,Sophie Tartare‐Deckert	167
17	Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness 2012 ·Journal of Molecular Cell Biology ·Alexandre Puissant,Maeva Dufies,Nina Fenouille,Issam Ben Sahra,Arnaud Jacquel,Guillaume Robert,Thomas Cluzeau,Marcel Deckert,Mélanie Tichet,Yann Chéli,(unknown),Sophie Raynaud,Laurence Legros,Jean‐Max Pasquet,François-Xavier Mahon,Frédéric Luciano,Patrick Auberger	32
18	SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival 2011 ·Oncogene ·Nina Fenouille,Alexandre Puissant,Mélanie Tichet,(unknown),Patricia Abbe,Aude Mallavialle,Stéphane Rocchi,Ortonne Jp,Marcel Deckert,Robert Ballotti,Sophie Tartare‐Deckert	53
19	The p53/p21^Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression 2010 ·Pigment Cell & Melanoma Research ·Nina Fenouille,Guillaume Robert,Mélanie Tichet,Alexandre Puissant,Maeva Dufies,Stéphane Rocchi,Jean‐Paul Ortonne,Marcel Deckert,Robert Ballotti,Sophie Tartare‐Deckert	36
20	Regulation of HLA class I surface expression requires CD99 and p230/golgin-245 interaction 2008 ·Blood ·(unknown),Ophélie Meynet,(unknown),(unknown),Mélanie Tichet,Katia Scotlandi,Jean‐Philippe Breittmayer,Pierre Gounon,Paul A. Gleeson,Alain Bernard,Ghislaine Bernard	42

About Mélanie Tichet

Mélanie Tichet is a scholar working on Oncology, Immunology and Rheumatology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Bone and Dental Protein Studies (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Oncology (441 citations), Immunology (303 citations) and Cancer Research (196 citations). Mélanie Tichet has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Sophie Tartare‐Deckert, Stéphane Rocchi, Marcel Deckert, Robert Ballotti, Douglas Hanahan, Nina Fenouille, Mickaël Ohanna, Aude Mallavialle, J.‐P. Lacour and Damien Giacchero. Their work appears in journals such as Science, Nature Communications and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact